1. Khalsa J, Gfroerer J . Epidemiology and health consequences of drug abuse among pregnant women. Semin Perinatol 1991; 15: 265–270.
2. Dicker M, Leighton E . Trends in diagnosed drug problems among newborns: United States, 1979–1987. Drug Alcohol Depend 1991; 28: 151–165.
3. Finnegan L, Connaughton J, Kron R . A scoring system for evaluation and treatment of the neonatal abstinence syndrome: a new clinical and research tool In: Marselli P, Garanttini S, Sereni F (eds). Basic and Therapeutic Aspects of Perinatal Pharmacology. Raven: New York, NY, USA, 1995 pp 139–152.
4. Patrick S, Schumacher R, Benneyworth B, Krans E, McAllister J, Davis M . Neonatal abstinence syndrome and associated health care expenditures United States, 2000-2009. JAMA 2012; 307: 1934–1940.
5. Doberczak T, Kandall S, Friedmann P . Relationships between maternal methadone dosage, maternal-neonatal methadone levels, and neonatal withdrawal. Obstet Gynecol 1993; 81: 936–940.